Resistance to Interferon of a Human Adenocarcinoma Cell Line, HEC-1, and its Sensitivity to Natural Killer Cell Action

References

1. Adams A., Strander H., Cantell K. 1975; Sensitivity of Epstein-Barr virus transformed human lymphoid cell lines to interferon. Journal of General Virology 28:207–214
   [Google Scholar]
2. Baglioni C. 1979; Interferon-induced enzymatic activities and their role in the antiviral state. Cell 17:255–264
   [Google Scholar]
3. Einhorn S., Blomgren H., Strander H. 1978; Interferon and spontaneous cytotoxicity in man. 1. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. International Journal of Cancer 22:405–412
   [Google Scholar]
4. Farrell P. J., Sen G. C., Dubois M. F., Ratner L., Slattery E., Lengyel P. 1978; Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proceedings of the National Academy of Sciences of the United States of America 75:5893–5897
   [Google Scholar]
5. Friedman R. M. 1978a; Interferon action and the cell surface. Pharmacology and Therapeutics 2:425–438
   [Google Scholar]
6. Friedman R. M. 1978b; The mechanism of action of interferon: possible primary effects on membrane. Horizons in Biochemistry and Biophysics 5:281–313
   [Google Scholar]
7. Fuchsberger N., Borecky L., Hajnicka V. 1974; Effect of prolonged interferon treatment on ‘L’ mouse fibroblast cells. Acta Virologica 18:85–87
   [Google Scholar]
8. Gidlund M., Orn A., Wigzell H., Senik A., Gresser I. 1978; Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature, London 273:759–761
   [Google Scholar]
9. Gresser I. 1977a; On the varied biologic effects of interferon. Cellular Immunology 34:406–415
   [Google Scholar]
10. Gresser I. 1977b; Antitumor effects of interferon. In Cancer-A Comprehensive Treatise pp 521–571 Edited by Becker F. F. New York: Plenum Press;
    [Google Scholar]
11. Gresser I., Tovey M. G. 1978; Antitumor effects of interferon. Biochimica et Biophysica Acta 516:231–247
    [Google Scholar]
12. Gresser I., Brouty-Boye D., Thomas M. T., Macieira-Coelho A. 1970; Interferon and cell division. 1. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparation. Proceedings of the National Academy of Sciences of the United States of America 66:1052–1058
    [Google Scholar]
13. Gresser I., Maury C., Brouty-Boye D. 1972; On the mechanism of the antitumor effect of interferon in mice. Nature, London 239:167–168
    [Google Scholar]
14. Gresser I., Bandu M.T., Brouty-Boye D. 1974; Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin. Journal of the National Cancer Institute 52:553–559
    [Google Scholar]
15. Gresser I., De Maeyer-Guignard J., Tovey M. G., De Maeyer E. 1979; Electrophoretically pure mouse interferon exerts multiple biologic effects. Proceedings of the National Academy of Sciences of the United States of America 76:5308–5312
    [Google Scholar]
16. Herberman R. B., Djieu J. Y., Kay H. D., Ortaldo J. R., Riccardi G. D., Bonnard D., Holden H. T., Fagnani R., Santoni A., Puccetti P. 1979; Natural killer cells: characteristics and regulation of activity. Immunological Reviews 44:43–70
    [Google Scholar]
17. Hilfenhaus J., Damm H., Johannsen R. 1977; Sensitivity of various human lymphoblastoid cells to the antiviral and anticellular activity of human leukocyte interferon. Archives of Virology 54:271–277
    [Google Scholar]
18. Huddlestone J. R., Merigan T. C. JR, Oldstone M. B. A. 1979; Induction and kinetics of natural killer cells in humans following interferon therapy. Nature, London 282:417–419
    [Google Scholar]
19. Huet C., Gresser I., Bandu M. T., Lindahl P. 1974; Increased binding of concanavalin A to interferon-treated murine leukemia L 1210 cells. Proceedings of the Society for Experimental Biology and Medicine 147:52–57
    [Google Scholar]
20. Kuramoto H., Tamura S., Notake Y. 1972; Establishment of a cell line of human endometrial adenocarcinoma in vitro. American Journal of Obstetrics and Gynecology 15:1012–1019
    [Google Scholar]
21. Kuwata T., Fuse A., Morinaga N. 1976; Effects of interferon on cell and virus growth in transformed human cell lines. Journal of General Virology 33:7–15
    [Google Scholar]
22. Kuwata T., Fuse A., Suzuki N., Morinaga N. 1979; Comparison of the suppression of cell and virus growth in transformed human cells by leukocyte and fibroblast interferon. Journal of General Virology 43:435–439
    [Google Scholar]
23. Kuwata T., Fuse A., Takayama N., Morinaga N. 1980; Effects of concanavalin A on the antiviral and cell growth inhibitory action of human interferons. Annals of the New York Academy of Sciences 350:211–228
    [Google Scholar]
24. Moore M., Potter M. R. 1980; Enhancement of human natural cell-mediated cytotoxicity by interferon. British Journal of Cancer 41:378–387
    [Google Scholar]
25. Moore M., White W. J., Potter M. R. 1980; Modulation of target cell susceptibility to human natural killer cells by interferon. International Journal of Cancer 25:565–572
    [Google Scholar]
26. Sato T., Fuse A., Kuwata T. 1979; Enhancement by interferon of natural cytotoxic activities of lymphocytes from human cord blood and peripheral blood of aged persons. Cellular Immunology 45:458–463
    [Google Scholar]
27. Schultz R. M., Chrigos M. A. 1978; Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations. Cancer Research 38:1003–1007
    [Google Scholar]
28. Slate D. L., Shulman U., Lawrence J. B., Revel M., Ruddle F. H. 1978; Presence of human chromosome 21 alone is sufficient for hybrid cell sensitivity to human interferon. Journal of Virology 25:319–325
    [Google Scholar]
29. Tan Y. H. 1977; Genetics of the human interferon system. In Interferons and Their Actions pp 73–90 Edited by Stewart W. E. II
    [Google Scholar]
30. Trinchieri G., Santoli D. 1978; Antiviral activity induced by culturing lymphocytes with tumor-derived or virus transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to Jysis. Journal of Experimental Medicine 147:1314–1333
    [Google Scholar]
31. Verhaegen M., Divizia M., Vandenbussche P., Kuwata T., Content J. 1980; Abnormal behaviour of interferon-induced enzymatic activities in an interferon-resistant cell line. Proceedings of the National Academy of Sciences of the United States of America 77:4479–4483
    [Google Scholar]